Literature DB >> 24210360

Prevalence of synchronous second primary malignancy: identification using whole body PET/CT imaging.

Wong Chun-Sing1, Gong Nan-Jie2, Chu Yiu-Ching3.   

Abstract

OBJECTIVE: To describe the prevalence of synchronous second primary malignancy detected by PET/ CT in our clinical practice and its differentiating features from metastatic lesion.
METHODS: All PET/CT scans from 1st October 2009 to 30th September 2010 were reviewed. The suspected cases of synchronous second primary malignancy detected by PET/CT were selected, and the histologically confirmed ones were being illustrated. Metachronous second primary cases were excluded.
RESULTS: A total of 1522 scans were reviewed. sixty-eight cases were suspected to have a synchronous second primary while 8 were histologically confirmed. Seven (0.4%) of them were malignant and 1 was a benign tumor. These 7 cases were illustrated, and we found a significant difference in SUV(max) values and site of occurrence unusual to metastasis that were the two main radiological features differentiating them from metastatic lesion.
CONCLUSION: Synchronous second primary malignancy could be missed without the use of whole body imaging. Its diagnosis is of utmost importance to prevent erroneous upstaging of disease and subsequent palliative treatment instead of curative surgery.
© 2013.

Entities:  

Keywords:  PET/CT; Synchronous second primary

Mesh:

Substances:

Year:  2013        PMID: 24210360     DOI: 10.1016/j.clinimag.2013.09.001

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  2 in total

1.  Primary Pulmonary Lymphoma and Synchronous Cecal Adenocarcinoma: A Rare Occurrence.

Authors:  Amina Saqib; Uroosa Ibrahim; Rabih Maroun
Journal:  Cureus       Date:  2016-12-27

2.  A Case of Metachronous Triple Carcinoma with Synchronous Double Primary Carcinoma on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography.

Authors:  Sarthak Tripathy; Asit Ranjan Mirdha; Shamim Ahmed Shamim; Girish Kumar Parida; Kishan Subudhi
Journal:  Indian J Nucl Med       Date:  2020-03-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.